5[1]Aguayo A,Estey E,Kantarjian H,et al.Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia.Blood,1999,94:3717-3721.
6[2]Aguayo A,Kantarjian H,Manshouri T,et al.Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.Blood,2000,96:2240-2245.
7[3]Verstovske S,Kantarjian H,Manshouri T,et al.Prognostic significance of VEGF protein levels in the bone marrow of patients with chronic myeloid leukemia.Blood,2000,96:740a.
8[4]Lunin S,Kantarjian H,Manshouri T,et al.Clinical relevance of Flk-1/KDR(VFGF-R2) and Flt-1(VEGF-R1) proteins in chronic myelogenous leukemia(CML).Blood,2000,96:350a.
9[7]Roboz GJ,Dias S,Lam G,et al.Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis.Blood,2000,96:1525-1530.
